Skip to content
Recall Observatory FDA recall evidence

Drug product

Adrenalin Chloride Solution (Epinephrine Nasal Solution, USP), 30mg/30mL (1mg/mL), packaged in 30 mL vials, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-103-01

D-0223-2025

December 20, 2024

Class I

Product summary

Firm
ENDO USA, Inc.
Event
Event 96013
Status
Ongoing
Classification
Class I
Quantity
44,397 amber glass vials
Official record key
drug-enforcement:D-0223-2025

Official wording

Reason: Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)

Code information: All lots within expiry

Distribution pattern: USA nationwide.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)